Sravan Kumar Emany insider trades

Open-market stock purchases and sales by Sravan Kumar Emany, Director at Assertio Holdings, Inc, from SEC Form 4 filings since Dec 6, 2021.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -62%.

Recent trades

DateStockTradeValue
Jun 16, 2026ASRT Assertio Holdings, IncSold (not open market)—
Jun 16, 2026ASRT Assertio Holdings, IncSold (not open market)$28.1K
Jun 16, 2026ASRT Assertio Holdings, IncSold (not open market)$50.1K
May 5, 2026ASRT Assertio Holdings, IncBought (not open market)—
Mar 31, 2026BEAM Beam Therapeutics IncBought (not open market)—
Feb 24, 2026KYTX Kyverna Therapeutics, IncBought (not open market)—
Feb 24, 2026KYTX Kyverna Therapeutics, IncBought (not open market)—
Jan 31, 2026BEAM Beam Therapeutics IncBought (not open market)—
Dec 31, 2025BEAM Beam Therapeutics IncSold$171K

Companies traded

  • ASRT Assertio Holdings, Inc: other filings, last Jun 16, 2026
  • BEAM Beam Therapeutics Inc: 1 sale, last Mar 31, 2026
  • KYTX Kyverna Therapeutics, Inc: other filings, last Feb 24, 2026
  • IRWD Ironwood Pharmaceuticals Inc: 2 buys, 2 sales, last Nov 18, 2024

Get free alerts when Sravan Kumar Emany files a new trade →